184 related articles for article (PubMed ID: 34928233)
1. HOXD3 Up-regulating KDM5C Promotes Malignant Progression of Diffuse Large B-Cell Lymphoma by Decreasing p53 Expression.
Cui Y; Lv C; Wen Y; Zhao D; Yang Y; Qiu H; Wang C
Balkan Med J; 2022 Jan; 39(1):30-38. PubMed ID: 34928233
[TBL] [Abstract][Full Text] [Related]
2. CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma.
Shen M; Zhang Y; Tang L; Fu Q; Zhang J; Xu Y; Zeng H; Li Y
BMC Cancer; 2023 Oct; 23(1):978. PubMed ID: 37833632
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance and detection of microRNA-21 in serum of patients with diffuse large B-cell lymphoma in Chinese population.
Chen W; Wang H; Chen H; Liu S; Lu H; Kong D; Huang X; Kong Q; Lu Z
Eur J Haematol; 2014; 92(5):407-12. PubMed ID: 24400911
[TBL] [Abstract][Full Text] [Related]
4. MiR-28-5p mediates the anti-proliferative and pro-apoptotic effects of curcumin on human diffuse large B-cell lymphoma cells.
Kang T; Sun WL; Lu XF; Wang XL; Jiang L
J Int Med Res; 2020 Jul; 48(7):300060520943792. PubMed ID: 32721183
[TBL] [Abstract][Full Text] [Related]
5. Geniposide inhibits proliferation and induces apoptosis of diffuse large B-cell lymphoma cells by inactivating the HCP5/miR-27b-3p/MET axis.
Hu L; Zhao J; Liu Y; Liu X; Lu Q; Zeng Z; Zhu L; Tong X; Xu Q
Int J Med Sci; 2020; 17(17):2735-2743. PubMed ID: 33162801
[TBL] [Abstract][Full Text] [Related]
6. [Antitumor Effect of Dihydroartemisinin on Diffuse Large B-Cell Lymphoma].
Zhang Y; Ma LH; Deng LL; Zhang ZM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1428-1434. PubMed ID: 36208245
[TBL] [Abstract][Full Text] [Related]
7. Decreased RNA‑binding protein IGF2BP2 downregulates NT5DC2, which suppresses cell proliferation, and induces cell cycle arrest and apoptosis in diffuse large B‑cell lymphoma cells by regulating the p53 signaling pathway.
Cui Y; Wen Y; Lv C; Zhao D; Yang Y; Qiu H; Wang C
Mol Med Rep; 2022 Sep; 26(3):. PubMed ID: 35894142
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.
Wang QM; Lian GY; Song Y; Huang YF; Gong Y
Life Sci; 2019 Aug; 231():116335. PubMed ID: 30898647
[TBL] [Abstract][Full Text] [Related]
9. Lysine demethylase 5C inhibits transcription of prefoldin subunit 5 to activate c-Myc signal transduction and colorectal cancer progression.
Yu F; Li L; Gu Y; Wang S; Zhou L; Cheng X; Jiang H; Huang Y; Zhang Y; Qian W; Li X; Liu Z
Mol Med; 2024 Jan; 30(1):9. PubMed ID: 38216914
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial pathway of the lysine demethylase 5C inhibitor CPI-455 in the Eca-109 esophageal squamous cell carcinoma cell line.
Xue XJ; Li FR; Yu J
World J Gastroenterol; 2021 Apr; 27(16):1805-1815. PubMed ID: 33967558
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B-cell lymphoma cells by targeting miR-497-5p/PIM1 axis.
Zhu Q; Li Y; Guo Y; Hu L; Xiao Z; Liu X; Wang J; Xu Q; Tong X
J Cell Mol Med; 2019 Nov; 23(11):7395-7405. PubMed ID: 31483572
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism of MiR-224 Affecting DLBCL Cell Proliferation and Invasion by Targeted Inhibition of PIK3CD].
Xie Y; Tan L; Li YT; Zeng Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1578-1584. PubMed ID: 33067957
[TBL] [Abstract][Full Text] [Related]
13. PMA/IONO affects diffuse large B-cell lymphoma cell growth through upregulation of A20 expression.
Yang W; Li Y; Li P; Wang L
Oncol Rep; 2016 Aug; 36(2):1069-75. PubMed ID: 27349720
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of circZNF609 targeting miR-153 to regulate the proliferation and apoptosis of diffuse large B-cell lymphoma].
Yang CS; Lou Y; Ke QP; Xu XJ; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):238-245. PubMed ID: 35316873
[No Abstract] [Full Text] [Related]
15. Dysregulated MDR1 by PRDM1/Blimp1 Is Involved in the Doxorubicin Resistance of Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
Qing K; Jin Z; Xu Z; Wang W; Li X; Zhang Y; Wang L; Zhu H; Xiang R; Wu S; Li R; Jiang G; Xue K; Li J
Chemotherapy; 2022; 67(1):12-23. PubMed ID: 34844236
[TBL] [Abstract][Full Text] [Related]
16. CXCL9 promotes the progression of diffuse large B-cell lymphoma through up-regulating β-catenin.
Ruiduo C; Ying D; Qiwei W
Biomed Pharmacother; 2018 Nov; 107():689-695. PubMed ID: 30130730
[TBL] [Abstract][Full Text] [Related]
17. DSF/Cu induces antitumor effect against diffuse large B-cell lymphoma through suppressing NF-κB/BCL6 pathways.
Zhu Y; Lei C; Jiang Q; Yu Q; Qiu L
Cancer Cell Int; 2022 Jul; 22(1):236. PubMed ID: 35883106
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA GClnc1 promotes progression of colorectal cancer by inhibiting p53 signaling pathway.
Dong YX; Pang ZG; Zhang JC; Hu JQ; Wang LY
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5705-5713. PubMed ID: 31298323
[TBL] [Abstract][Full Text] [Related]
19. microRNA-181a promotes the oncogene S100A2 and enhances papillary thyroid carcinoma growth by mediating the expression of histone demethylase KDM5C.
Wang Y; Ye H; Yang Y; Li J; Cen A; Zhao L
J Endocrinol Invest; 2022 Jan; 45(1):17-28. PubMed ID: 34143366
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs.
Mathur R; Sehgal L; Havranek O; Köhrer S; Khashab T; Jain N; Burger JA; Neelapu SS; Davis RE; Samaniego F
Haematologica; 2017 Feb; 102(2):373-380. PubMed ID: 27742770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]